0001104659-23-126930.txt : 20231218
0001104659-23-126930.hdr.sgml : 20231218
20231218170033
ACCESSION NUMBER: 0001104659-23-126930
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231214
FILED AS OF DATE: 20231218
DATE AS OF CHANGE: 20231218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rubin Jonathan
CENTRAL INDEX KEY: 0001836067
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35518
FILM NUMBER: 231494547
BUSINESS ADDRESS:
BUSINESS PHONE: 3018382500
MAIL ADDRESS:
STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC.
STREET 2: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001356576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-838-2500
MAIL ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060317
4
1
tm2333121-1_4seq2.xml
OWNERSHIP DOCUMENT
X0508
4
2023-12-14
0
0001356576
SUPERNUS PHARMACEUTICALS, INC.
SUPN
0001836067
Rubin Jonathan
C/O SUPERNUS PHARMACEUTICALS, INC.,
9715 KEY WEST AVENUE
ROCKVILLE
MD
20850
0
1
0
0
SVP, Chief Medical Officer
0
Common Stock
2847
D
Performance Share Unit
0
2023-12-14
4
A
0
600
0
A
Common Stock
600
600
D
Includes an aggregate of 350 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022.
/s/ Timothy C. Dec, as attorney-in-fact
2023-12-18